Clinical Trials Directory

Trials / Completed

CompletedNCT01598844

JUPITER Study: Transapical Aortic Valve Implantation for Aortic Regurgitation

The JenaValve" EvalUation of Long Term Performance and Safety In PaTients With SEvere Aortic Stenosis oR Aortic Insufficiency

Status
Completed
Phase
Study type
Observational
Enrollment
210 (actual)
Sponsor
JenaValve Technology, Inc. · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this registry is to observe longterm performance and safety of the JenaValve TAVI system, in routine medical and everyday conditions.

Detailed description

The objective of this study is to evaluate the long term safety and effectiveness of the CE-marked JenaValve System Transapical in an elderly patient population with severe aortic stenosis and/or aortic insufficiency who are at high risk for open surgical aortic valve replacement. The target study population will consist of elderly patients suffering from severe symptomatic degenerative aortic valve stenosis and/or aortic insufficiency who show an increased risk for an open aortic valve replacement surgery due to existing co-morbidities.

Conditions

Interventions

TypeNameDescription
DEVICETranscatheter aortic valve replacementTranscatheter aortic valve replacement via a transapical access

Timeline

Start date
2012-05-30
Primary completion
2015-08-27
Completion
2018-07-31
First posted
2012-05-15
Last updated
2020-11-24

Locations

15 sites across 4 countries: Germany, Netherlands, Switzerland, United Kingdom

Source: ClinicalTrials.gov record NCT01598844. Inclusion in this directory is not an endorsement.